BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25127463)

  • 1. 2-Phenylaminonaphthoquinones and related compounds: synthesis, trypanocidal and cytotoxic activities.
    Sieveking I; Thomas P; Estévez JC; Quiñones N; Cuéllar MA; Villena J; Espinosa-Bustos C; Fierro A; Tapia RA; Maya JD; López-Muñoz R; Cassels BK; Estévez RJ; Salas CO
    Bioorg Med Chem; 2014 Sep; 22(17):4609-20. PubMed ID: 25127463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
    Carneiro PF; do Nascimento SB; Pinto AV; Pinto Mdo C; Lechuga GC; Santos DO; dos Santos Júnior HM; Resende JA; Bourguignon SC; Ferreira VF
    Bioorg Med Chem; 2012 Aug; 20(16):4995-5000. PubMed ID: 22795899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
    Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
    Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms.
    Salas C; Tapia RA; Ciudad K; Armstrong V; Orellana M; Kemmerling U; Ferreira J; Maya JD; Morello A
    Bioorg Med Chem; 2008 Jan; 16(2):668-74. PubMed ID: 18029184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological characterization of new aryloxyindole-4,9-diones as potent trypanosomicidal agents.
    Tapia RA; Salas CO; Vázquez K; Espinosa-Bustos C; Soto-Delgado J; Varela J; Birriel E; Cerecetto H; González M; Paulino M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3919-22. PubMed ID: 25008454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of naphthofuranquinones with activity against Trypanosoma cruzi.
    Silva RS; Costa EM; Trindade UL; Teixeira DV; Pinto Mde C; Santos GL; Malta VR; De Simone CA; Pinto AV; de Castro SL
    Eur J Med Chem; 2006 Apr; 41(4):526-30. PubMed ID: 16500733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-Trypanosoma cruzi activity of naphthoquinone-containing triazoles: electrochemical studies on the effects of the quinoidal moiety.
    Diogo EB; Dias GG; Rodrigues BL; Guimarães TT; Valença WO; Camara CA; de Oliveira RN; da Silva MG; Ferreira VF; de Paiva YG; Goulart MO; Menna-Barreto RF; de Castro SL; da Silva Júnior EN
    Bioorg Med Chem; 2013 Nov; 21(21):6337-48. PubMed ID: 24074878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antichagasic properties of new 1,2,6-thiadiazin-3,5-dione 1,1-dioxides and related compounds.
    Di Maio R; Cerecetto H; Seoane G; Ochoa C; Arán VJ; Pérez E; Gómez Barrio A; Muelas S
    Arzneimittelforschung; 1999 Sep; 49(9):759-63. PubMed ID: 10514904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
    da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
    Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the search for potential anti-Trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions.
    da Silva Júnior EN; de Melo IM; Diogo EB; Costa VA; de Souza Filho JD; Valença WO; Camara CA; de Oliveira RN; de Araujo AS; Emery FS; dos Santos MR; de Simone CA; Menna-Barreto RF; de Castro SL
    Eur J Med Chem; 2012 Jun; 52():304-12. PubMed ID: 22483633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi: in vitro activity of Epoxy-alpha-Lap, a derivative of alpha-lapachone, on trypomastigote and amastigote forms.
    Bourguignon SC; Castro HC; Santos DO; Alves CR; Ferreira VF; Gama IL; Silva FC; Seguins WS; Pinho RT
    Exp Parasitol; 2009 Jun; 122(2):91-6. PubMed ID: 19285074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against
    Lara LS; Lechuga GC; Moreira CDS; Santos TB; Ferreira VF; da Rocha DR; Pereira MCS
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi.
    Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC
    Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New benzimidazolequinones as trypanosomicidal agents.
    López-Lira C; Tapia RA; Herrera A; Lapier M; Maya JD; Soto-Delgado J; Oliver AG; Graham Lappin A; Uriarte E
    Bioorg Chem; 2021 Jun; 111():104823. PubMed ID: 33798844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
    Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
    Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New aryloxy-quinone derivatives with promising activity on Trypanosoma cruzi.
    Espinosa-Bustos C; Vázquez K; Varela J; Cerecetto H; Paulino M; Segura R; Pizarro J; Vera B; González M; Zarate AM; Salas CO
    Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900213. PubMed ID: 31709599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro antitrypanosomal activity of novel Nifurtimox analogues.
    Pozas R; Carballo J; Castro C; Rubio J
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1417-21. PubMed ID: 15713399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones.
    da Silva Júnior EN; de Souza MC; Fernandes MC; Menna-Barreto RF; Pinto Mdo C; de Assis Lopes F; de Simone CA; Andrade CK; Pinto AV; Ferreira VF; de Castro SL
    Bioorg Med Chem; 2008 May; 16(9):5030-8. PubMed ID: 18378461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-parasitic activity of Cyclosporin A analogs on Trypanosoma cruzi.
    Búa J; Ruiz AM; Potenza M; Fichera LE
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4633-7. PubMed ID: 15324878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.